Literature DB >> 10623643

Growth efficiency in transgenic tilapia (Oreochromis sp.) carrying a single copy of an homologous cDNA growth hormone.

R Martínez1, J Juncal, C Zaldívar, A Arenal, I Guillén, V Morera, O Carrillo, M Estrada, A Morales, M P Estrada.   

Abstract

Growth hormone (GH) has been shown to have a profound impact on fish physiology and metabolism. However, detailed studies in transgenic fish have not been conducted. We have characterized the food conversion efficiency, protein profile, and biochemical correlates of growth rate in transgenic tilapia expressing the tilapia GH cDNA under the control of human cytomegalovirus regulatory sequences. Transgenic tilapia exhibited about 3.6-fold less food consumption than nontransgenic controls (P < 0.001). The food conversion efficiency was significantly (P < 0.05) higher (290%) in transgenic tilapia (2.3 +/- 0.4) than in the control group (0.8 +/- 0.2). Efficiency of growth, synthesis retention, anabolic stimulation, and average protein synthesis were higher in transgenic than in nontransgenic tilapia. Distinctive metabolic differences were found in transgenic juvenile tilapia. We had found differences in hepatic glucose, and in agreement with previous results we observed differences in the level of enzymatic activities in target organs. We conclude that GH-transgenic juvenile tilapia show altered physiological and metabolic conditions and are biologically more efficient. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623643     DOI: 10.1006/bbrc.1999.1956

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Fish can be first--advances in fish transgenesis for commercial applications.

Authors:  Halina M Zbikowska
Journal:  Transgenic Res       Date:  2003-08       Impact factor: 2.788

2.  Gene transfer and mutagenesis mediated by Sleeping Beauty transposon in Nile tilapia (Oreochromis niloticus).

Authors:  Xiaozhen He; Jie Li; Yong Long; Guili Song; Peiyong Zhou; Qiuxiang Liu; Zuoyan Zhu; Zongbin Cui
Journal:  Transgenic Res       Date:  2013-02-19       Impact factor: 2.788

3.  Production of transgenic tilapia with Brockmann bodies secreting [desThrB30] human insulin.

Authors:  Bill Pohajdak; Marc Mansour; Olga Hrytsenko; J Michael Conlon; L Clayton Dymond; James R Wright
Journal:  Transgenic Res       Date:  2004-08       Impact factor: 2.788

4.  Precision genetics for complex objectives in animal agriculture.

Authors:  S C Fahrenkrug; A Blake; D F Carlson; T Doran; A Van Eenennaam; D Faber; C Galli; Q Gao; P B Hackett; N Li; E A Maga; W M Muir; J D Murray; D Shi; R Stotish; E Sullivan; J F Taylor; M Walton; M Wheeler; B Whitelaw; B P Glenn
Journal:  J Anim Sci       Date:  2010-03-12       Impact factor: 3.159

5.  Sexually Dimorphic Growth Stimulation in a Strain of Growth Hormone Transgenic Coho Salmon (Oncorhynchus kisutch).

Authors:  Michelle T T Chan; Annette Muttray; Dionne Sakhrani; Krista Woodward; Jin-Hyoung Kim; Kris A Christensen; Ben F Koop; Robert H Devlin
Journal:  Mar Biotechnol (NY)       Date:  2021-01-22       Impact factor: 3.619

6.  Improved liver lipid catabolism and utilization in growth hormone transgenic common carp (Cyprinus carpio L.) through enhanced lipolytic and fatty acid β-oxidation pathways.

Authors:  Yunya Wu; Rui Li; Xingxing Wu; Wei Guo; Yongming Li; Yanlong Song; Binbin Tao; Ji Chen; Dong Han; Shouqi Xie; Yaping Wang; Zuoyan Zhu; Wei Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-12       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.